Response to the letter from Dr Cosolo and Colleagues

par Pearson, A.D.J.
Publié 1992

Schedule-dependent response of neuroblastoma cell lines to combinations of etoposide and cisplatin

par Meczes, E L, Pearson, A D J, Austin, C A, Tilby, M J
Publié 2002

Dose-related nephrotoxicity of carboplatin in children

par English, M W, Skinner, R, Pearson, A D J, Price, L, Wyllie, R, Craft, A W
Publié 1999

Two families with the Li-Fraumeni cancer family syndrome

par Pearson, A D J, Craft, A W, Ratcliffe, J M, Birch, J M, Morris-Jones, P, Roberts, D F
Publié 1982

Increasing the intracellular availability of all-trans retinoic acid in neuroblastoma cells

par Armstrong, J L, Ruiz, M, Boddy, A V, Redfern, C P F, Pearson, A D J, Veal, G J
Publié 2005

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer

par Willits, I, Price, L, Parry, A, Tilby, M J, Ford, D, Cholerton, S, Pearson, A D J, Boddy, A V
Publié 2005

Estimation of glomerular filtration rate in paediatric cancer patients using (51)CR-EDTA population pharmacokinetics

par Cole, M, Price, L, Parry, A, Keir, M J, Pearson, A D J, Boddy, A V, Veal, G J
Publié 2004

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

par Matthay, K K, Shulkin, B, Ladenstein, R, Michon, J, Giammarile, F, Lewington, V, Pearson, A D J, Cohn, S L
Publié 2010

Pharmacokinetics and metabolism of 13-cis-retinoic acid (isotretinoin) in children with high-risk neuroblastoma – a study of the United Kingdom Children's Cancer Study Group

par Veal, G J, Cole, M, Errington, J, Pearson, A D J, Foot, A B M, Whyman, G, Boddy, A V
Publié 2007

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the Int...

par Beiske, K, Burchill, S A, Cheung, I Y, Hiyama, E, Seeger, R C, Cohn, S L, Pearson, A D J, Matthay, K K
Publié 2009

Fluorescence in situ hybridization techniques for the rapid detection of genetic prognostic factors in neuroblastoma

par Taylor, C P F, Bown, N P, McGuckin, A G, Lunec, J, Malcolm, A J, Pearson, A D J, Sheer, D
Publié 2000

Adaptive dosing and platinum–DNA adduct formation in children receiving high-dose carboplatin for the treatment of solid tumours

par Veal, G J, Errington, J, Tilby, M J, Pearson, A D J, Foot, A B M, McDowell, H, Ellershaw, C, Pizer, B, Nowell, G M, Pearson, D G, Boddy, A V
Publié 2007

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

par Ambros, P F, Ambros, I M, Brodeur, G M, Haber, M, Khan, J, Nakagawara, A, Schleiermacher, G, Speleman, F, Spitz, R, London, W B, Cohn, S L, Pearson, A D J, Maris, J M
Publié 2009

A phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatin

par Veal, G J, Griffin, M J, Price, E, Parry, A, Dick, G S, Little, M A, Yule, S M, Morland, B, Estlin, E J, Hale, J P, Pearson, A D J, Welbank, H, Boddy, A V
Publié 2001

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group

par De Bernardi, B, Mosseri, V, Rubie, H, Castel, V, Foot, A, Ladenstein, R, Laureys, G, Beck-Popovic, M, de Lacerda, A F, Pearson, A D J, De Kraker, J, Ambros, P F, de Rycke, Y, Conte, M, Bruzzi, P, Michon, J
Publié 2008

A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation

par Estlin, E J, Pinkerton, C R, Lewis, I J, Lashford, L, McDowell, H, Morland, B, Kohler, J, Newell, D R, Boddy, A V, Taylor, G A, Price, L, Ablett, S, Hobson, R, Pitsiladis, M, Brampton, M, Clendeninn, N, Johnston, A, Pearson, A D J
Publié 2001

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project

par Schleiermacher, G, Mosseri, V, London, W B, Maris, J M, Brodeur, G M, Attiyeh, E, Haber, M, Khan, J, Nakagawara, A, Speleman, F, Noguera, R, Tonini, G P, Fischer, M, Ambros, I, Monclair, T, Matthay, K K, Ambros, P, Cohn, S L, Pearson, A D J
Publié 2012

Joint adolescent–adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform—ACCELERATE

par Gaspar, N, Marshall, L V, Binner, D, Herold, R, Rousseau, R, Blanc, P, Capdeville, R, Carleer, J, Copland, C, Kerloeguen, Y, Norga, K, Pacaud, L, Sevaux, M -A, Spadoni, C, Sterba, J, Ligas, F, Taube, T, Uttenreuther-Fischer, M, Chioato, S, O'Connell, M A, Geoerger, B, Blay, J -Y, Soria, J C, Kaye, S, Wulff, B, Brugières, L, Vassal, G, Pearson, A D J
Publié dans Ann Oncol (2018)